Category: Orthopedic Injectables Articles

Managing knee osteoarthritis (OA) pain is a significant challenge in clinical practice, impacting patient mobility and quality of life. When foundational therapies fall short, intra-articular viscosupplementation with hyaluronic acid (HA) is a well-established treatment option. Among the available HA products, Monovisc® (by Anika Therapeutics) stands out due to its single-injection administration protocol and non-avian derived …

Monovisc® for Knee OA: Efficacy & Convenience of Single-Injection HARead More

Hymovis® (Fidia Farmaceutici) offers a distinct approach to knee osteoarthritis (OA) pain relief. This HA viscosupplement uses HYADD®4 hydrogel technology for prolonged joint action, delivered in a two-injection series. This guide details its technology, clinical use, and safety for medical professionals. (This guide is for trained medical professionals experienced in intra-articular injections. Adherence product guidelines …

Hymovis® for Knee OsteoarthritisRead More

Managing the pain and functional limitations caused by knee osteoarthritis (OA) often requires a multimodal approach. While exercise, weight management, and oral medications form the initial steps, many patients benefit from intra-articular injections. These can include hyaluronic acid (HA) viscosupplements or corticosteroids. Cingal®, developed by Anika Therapeutics, offers a unique evolution in this space: a …

Single-Injection HA/Steroid Therapy: Understanding Cingal® for Knee OARead More

Managing knee osteoarthritis (OA) presents a significant clinical challenge, often impacting patient mobility, function, and overall quality of life. While conservative measures like physical therapy, weight management, and pharmacologic agents form the foundation of care, many patients require additional interventions to achieve adequate symptom control. Intra-articular viscosupplementation has emerged as a valuable component within the …

Choosing Synvisc or Synvisc-One for Knee OARead More

The management of knee osteoarthritis (OA) increasingly seeks solutions that are both effective and align with patient needs for convenience and reduced treatment burden. As conservative therapies prove insufficient for many patients, intra-articular viscosupplementation remains a key non-surgical option. The evolution within this field has seen a notable shift towards single-injection HA (hyaluronic acid) regimens, …

Monovisc®: Single Injection for Knee OA PainRead More

Osteoarthritis (OA) of the knee is a prevalent condition impacting millions, causing pain and functional limitations. Viscosupplementation, the practice of injecting hyaluronic acid (HA) into the knee joint, is a widely used non-surgical option to manage symptoms by supplementing the joint’s natural lubricating fluid. Among the many available HA products, Euflexxa® (by Ferring Pharmaceuticals) and …

Euflexxa vs. Monovisc: 3-Dose vs. 1-Dose Knee OARead More

Knee osteoarthritis (OA) is a widespread and often debilitating condition causing pain, stiffness, and functional limitation in individuals worldwide. When conservative therapies fail to provide adequate relief, intra-articular injections are a common intervention to manage symptoms. Viscosupplementation, involving the injection of hyaluronic acid (HA) into the knee joint, is an established approach aimed at supplementing …

Euflexxa® for Knee OsteoarthritisRead More

Osteoarthritis (OA) is a widespread degenerative joint disease causing significant pain, stiffness, and functional limitation for millions globally. When conservative measures like analgesics and physical therapy prove insufficient, intra-articular injections become a valuable treatment option. Cingal®, developed by Anika Therapeutics, offers a unique single-injection approach by combining cross-linked hyaluronic acid (HA) with a corticosteroid, triamcinolone …

Cingal® for Osteoarthritis Pain: A Practitioner’s GuideRead More